Navigation Links
Nicotine-Reduced Cigarettes Could Boost Quitting
Date:11/14/2007

A gradual lessening of the drug may ease addiction, research suggests

WEDNESDAY, Nov. 14 (HealthDay News) -- Providing smokers with cigarettes of gradually decreasing levels of nicotine over a number of weeks can help cut their nicotine addiction, a U.S. study finds.

The study, conducted by researchers at the University of California, San Francisco, and San Francisco General Hospital Medical Center, included 20 adult smokers. They puffed on their usual brand for the first week of the study and then began a six-week program where they smoked cigarettes with steadily decreasing amounts of nicotine.

At the end of the six weeks, the smokers were free to start using their regular cigarette brands again, which most did. However, when checked a month later, they were smoking about 40 percent fewer cigarettes a day compared to when the study began.

The researchers also noted that about 25 percent of the smokers quit smoking entirely during the study.

The findings are published in the Nov. 14 issue of the journal Cancer Epidemiology, Biomarkers & Prevention.

"This study supports the idea that if tobacco companies were required to reduce the levels of nicotine in cigarette tobacco, young people who start smoking could avoid becoming addicted, and long-time smokers could reduce or end their smoking. This could spare millions of people from the severe health effects of long-term smoking," study team leader Dr. Neal Benowitz, professor of medicine, psychiatry and biopharmaceutical sciences, and chief, division of clinical pharmacology and experimental therapeutics at SFGH, said in a prepared statement.

Currently, the U.S. Congress is considering proposals to give the U.S. Food and Drug Administration authority to regulate tobacco products, including the reduction of nicotine levels in cigarettes.

More information

The U.S. Centers for Disease Control and Prevention has mo
'/>"/>

Copyright©2007 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Filtered Cigarettes Blamed for Huge Rise in Type of Lung Cancer
2. Study provides hope that some transplant patients could live free of antirejection drugs
3. Study provides hope that some transplant patients could live free of anti-rejection drugs
4. HIV denialists spread misinformation online -- consequences could be deadly; and more
5. Virus Could Help Drive Obesity
6. Discovery of sugar sensor in intestine could benefit diabetes
7. Cranberry Could Juice Up Ovarian Cancer Treatment
8. Treating Diabetes During Pregnancy Could Lead to Thinner Kids
9. High-risk behaviors could lead to HIV epidemic in Afghanistan
10. Chinas 1-child policy could backfire on its elderly
11. 1.5 million children could be saved
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...local dance students will dance to raise money for...S, Jan. 8 , , , WHO: ...how off their talent in the 3rd annual Dance, ...nce Arts Centre. The, event will ..., Participants raise money throug...
(Date:1/8/2009)..., Md., Jan. 8 /PRNewswire-Asia/ -- Chindex Interna...mpany"), a leading independent American,provider ... People,s Republic,of China, today announced that...na Conference, to be held in Shanghai on January 1...Conference will be held at the Pudong Shangri-,La...
(Date:1/8/2009)...romoted to Principal. Christine Siu and Jason Bro...POLIS, SAN FRANCISCO and STAMFORD, Conn., Jan. 8 /...health care venture capital firm that invests in l...y announced the promotion of three members of its ...Principal. Christine Siu and Jason Brown have bee...
(Date:1/8/2009)... Tenn., Jan. 8 St. Jude Children,s...p announced that FedExCup Runner-Up,Camilo Villeg...Jude with a,pledge to match Singh,s donation of $... 2009 PGA TOUR. Eagles for St. Jude is a powerful...ion Vijay Singh and rising LPGA star Morgan,Press...
Breaking Medicine News(10 mins):Health News:Dance With Courage to Benefit Camp Courage 2Health News:Chindex International Inc. Announces Participation in the 2009 UBS Greater China Conference 2Health News:Thomas, McNerney & Partners Promotes Three Members of Its Investment Team 2Health News:Not to be Outdone by FedExCup Champion Vijay Singh, FedExCup Runner-Up Camilo Villegas Increases Commitment to Children of St. Jude 2Health News:Not to be Outdone by FedExCup Champion Vijay Singh, FedExCup Runner-Up Camilo Villegas Increases Commitment to Children of St. Jude 3Health News:Not to be Outdone by FedExCup Champion Vijay Singh, FedExCup Runner-Up Camilo Villegas Increases Commitment to Children of St. Jude 4
...gers drawn on many issues, however one issue that ...ent in India of 70 poor Pakistani children later t...s likely to pave path towards many more similar ge... the two countries that politician on both sides o...
... stents that release the medication paclitaxel red...nths following angioplasty for patients with compl...e in the September 14 issue of JAMA. Drug-eluting ... of atherosclerotic coronary artery disease, accor...
...n Uttar Pradesh crossed 800 Saturday. But the admi... believed to be at the root of the virtual epidemi...orse as the animal is known to be the biggest host...carried across to human beings by mosquitoes. Utt...
... the heart from the use of stem cells. French rese...o repair heart damage in sheep, reporting their re...ncet. Heart failure is a major cause of death in d... when cells within the heart are damaged after a h...
Other Medicine News:Health News:Surgeons in India to Mend ‘Pakistani Hearts’ by treating 70 Childr 2Health News:Stents That Release Medication To Check Artery Narrowing 2Health News:Pigs Population A Major Threat To Encephalitis Ravaged UP 2
(Date:1/5/2009)...e/ -- Cylene Pharmaceuticals announced today that ...ral CK2 protein kinase inhibitor, CX-4945, in pati...se, or multiple myeloma. The primary endpoints of ...f safety, tolerance and PK properties of CX-4945 a...als. In addition, multiple mechanism-related pharm...
(Date:12/30/2008)...ire-USNewswire/ -- The Coalition for 21st Century ...ed by Genentech, Inc. on December 5, 2008, seeking...diagnostic tests to physicians and patients. The ...would harm patient care and rests on flawed scient...ssion is to encourage the research, development, a...
(Date:12/27/2008)...-year silence, offers to ease cloning costs for Cl...S, Dec. 27 Six years to...oned child, Dr. Brigitte Boisselier, head of the c...d other babies cloned by her company are growing u...eir families, privacy. , , "We,ve helped almost...
(Date:12/17/2008)...wswire/ -- PEAK Surgical, Inc., a medical,device ... system based on a,proprietary technology, announ...ion (FDA) has granted the company 510(k) clearance... and coagulation of soft tissue during,plastic an...cologic,orthopedic, arthroscopic, spinal and neu...
Breaking Medicine Technology:Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 2Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 3Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients 2Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients 3Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients 4'We're Ready to Prove It!' 2PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 2PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 3PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 4Breckenridge Pharmaceutical Enters Agreement With Helm AG 28Hamburg Germany 29 to Develop Additional ANDA Project 15702 1CV Therapeutics Anti Ischemic Therapy Ranexa 28R 29 Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN TIMI 36 Patient 1666 1CV Therapeutics Anti Ischemic Therapy Ranexa 28R 29 Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN TIMI 36 Patient 1666 2CV Therapeutics Anti Ischemic Therapy Ranexa 28R 29 Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN TIMI 36 Patient 1666 3mtvU Unleashes Month OF Exclusive Album Leaks 26 Music Video Premieres in Continued Fight Against Darfur Genocide 15697 1mtvU Unleashes Month OF Exclusive Album Leaks 26 Music Video Premieres in Continued Fight Against Darfur Genocide 15697 2mtvU Unleashes Month OF Exclusive Album Leaks 26 Music Video Premieres in Continued Fight Against Darfur Genocide 15697 3mtvU Unleashes Month OF Exclusive Album Leaks 26 Music Video Premieres in Continued Fight Against Darfur Genocide 15697 4mtvU Unleashes Month OF Exclusive Album Leaks 26 Music Video Premieres in Continued Fight Against Darfur Genocide 15697 5Final Data From the Bioheart Seismic Trial Suggest Safety Efficacy of Autologous Stem Cell Therapy for Treating Congestive Heart Failure 1664 1Final Data From the Bioheart Seismic Trial Suggest Safety Efficacy of Autologous Stem Cell Therapy for Treating Congestive Heart Failure 1664 2Final Data From the Bioheart Seismic Trial Suggest Safety Efficacy of Autologous Stem Cell Therapy for Treating Congestive Heart Failure 1664 3Final Data From the Bioheart Seismic Trial Suggest Safety Efficacy of Autologous Stem Cell Therapy for Treating Congestive Heart Failure 1664 4Final Data From the Bioheart Seismic Trial Suggest Safety Efficacy of Autologous Stem Cell Therapy for Treating Congestive Heart Failure 1664 5Final Data From the Bioheart Seismic Trial Suggest Safety Efficacy of Autologous Stem Cell Therapy for Treating Congestive Heart Failure 1664 6
...SS WIRE)--Mar 26, 2007 - A study comparing,the for...lazine,(HYD) used in V-HeFT I and V-HeFT II, and B... in the African American Heart Failure,Trial (A-He...ence,in the formulations used may explain why V-He...n decreasing mortality. Using,identical amounts of...
...already being treated with maximally,tolerated lip...ctions in LDL-C with similar reductions in other a...12, NEW ORLEANS, and CARLSBAD, Calif., March 26, 2..., Inc. announced,results from its ongoing Phase 2 ...ozygous familial hypercholesterolemia (HoFH),pres...
Other Medicine Technology:Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 2Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 3Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 4Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 5Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 2Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 3Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 4Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 5Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 6
Central platform with integrated neck. Piston assembly fits into neck of platform utilizing an internal spring to recoil to ready position after use. Cutting block fits into precision milled cavity i
TLS Surgical Markers allows the surgeon to effectively diagram incision sites with a scrub-resistant, gentian violet ink. All TLS Surgical Markers are provided sterile, with a ruler and are individua
Periosteal elevator, freer.
The Surgifoam* absorbable gelatin sponge, U.S.P. is a sterile, water-insoluble, malleable, porcine gelatin absorbable sponge intended for hemostatic use by applying to a bleeding surface. The sponge
Medicine Products: